With more than 1000 Tons yearly capacity, micromacinazione SA has the largest European capability.

We currently process more than 100 different API per year, and we have experience with more than 700 products.

Each API processed is registered in our files, and the original Batch Record is kept for 10 years available for our customers.

Steroids are fully segregated into dedicated rooms. Currently 22 mills are installed in our three plants. Our equipments.

Cytotoxic compounds are micronized in dedicated Glove Box.

Special procedures with microbiological analysis of environment and powder are followed for micronization of API for inhaler: Inhalation Product Micronization (IPM).

Through the affiliate Micro-Sphere SA, the Group is also in position to perform contract development of liquid and dry micro-encapsulated formulations of active pharmaceutical ingredients, including peptides, proteins and DNA.

Micro-Sphere SA has the capability to offer contract manufacturing from laboratory up to pilot scale utilizing the following technologies:

Micromacinazione takes over micronization division of Neo-Micro AG

A novel engineering platform to enhance the dissolution rate of poorly soluble drugs.

Cross acquires a majority stake in Micromacinazione as part of a succession solution.

We are glad to announce that recently (28-30 March 2012) we passed a 3-day FDA inspection successfully at both our manufacturing sites, Molinazzo di Monteggio and Madonna del Piano, without any observation.

Possibility to produce nanoparticles by super- critical fluid precipitation under fully cGMP conditions.